MVP: Sullivan & Cromwell's Matt Hurd

Law360 (October 19, 2023, 1:08 PM EDT) -- Matt Hurd of Sullivan & Cromwell LLP recently led Pfizer's acquisition of Seagen, a global biotech company specializing in cancer medicines, in a $43 billion all-cash deal, earning him a spot...

To view the full article, register now.